EXLS Stock - ExlService Holdings, Inc.
Unlock GoAI Insights for EXLS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.84B | $1.63B | $1.41B | $1.12B | $958.43M |
| Gross Profit | $691.01M | $607.77M | $515.45M | $431.36M | $334.50M |
| Gross Margin | 37.6% | 37.3% | 36.5% | 38.4% | 34.9% |
| Operating Income | $263.62M | $238.75M | $192.16M | $155.88M | $110.02M |
| Net Income | $198.30M | $184.56M | $142.97M | $114.76M | $89.48M |
| Net Margin | 10.8% | 11.3% | 10.1% | 10.2% | 9.3% |
| EPS | $1.22 | $1.11 | $0.86 | $0.68 | $0.52 |
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 9th 2024 | Jefferies | Upgrade | Buy | $42← $35 |
| May 8th 2024 | Wedbush | Upgrade | Outperform | $40← $34 |
| January 17th 2024 | Citigroup | Upgrade | Buy | $36← $29 |
| September 19th 2023 | Jefferies | Initiation | Hold | $33 |
| March 15th 2023 | Citigroup | Upgrade | Neutral | $160 |
| July 29th 2022 | Needham | Upgrade | Buy | $190 |
| July 20th 2022 | Citigroup | Downgrade | Sell | $134← $150 |
Earnings History & Surprises
EXLSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $0.46 | — | — | — |
Q4 2025 | Oct 28, 2025 | $0.47 | $0.48 | +3.2% | ✓ BEAT |
Q3 2025 | Jul 29, 2025 | $0.45 | $0.49 | +8.9% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $0.45 | $0.48 | +6.7% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $0.42 | $0.44 | +4.8% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $0.41 | $0.44 | +7.3% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.39 | $0.40 | +2.6% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.36 | $0.38 | +5.6% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $0.34 | $0.35 | +2.9% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $0.34 | $0.37 | +8.8% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $0.34 | $0.36 | +5.9% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.32 | $0.35 | +9.4% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $0.29 | $0.31 | +6.9% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.28 | $0.31 | +10.7% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.27 | $0.30 | +11.1% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $0.26 | $0.28 | +7.7% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $0.23 | $0.24 | +4.3% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $0.21 | $0.26 | +23.8% | ✓ BEAT |
Q3 2021 | Jul 29, 2021 | $0.20 | $0.23 | +15.0% | ✓ BEAT |
Latest News
EXL Repurchases 1,551,970 Shares From Orogen For $63.4M In Private Transaction Separate From Repurchase Program
➖ NeutralExlService Raises FY2025 Adj EPS Guidance from $1.86-$1.90 to $1.88-$1.92 vs $1.90 Est; Raises FY2025 Sales Guidance from $2.050B-$2.070B to $2.070B-$2.080B vs $2.069B Est
📈 PositiveExlService Holdings Q3 Adj. EPS $0.48 Beats $0.47 Estimate, Sales $529.585M Beat $522.472M Estimate
📈 PositiveEXL Launches EXLdata.ai In Partnership With Databricks To Accelerate Enterprise AI Adoption
📈 PositiveFrequently Asked Questions about EXLS
What is EXLS's current stock price?
What is the analyst price target for EXLS?
What sector is ExlService Holdings, Inc. in?
What is EXLS's market cap?
Does EXLS pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to EXLS for comparison